Data / Form D filings / Grannus Therapeutics, Inc.
Grannus Therapeutics, Inc.: Form D filings
Grannus Therapeutics, Inc., a biotechnology company in Indianapolis, IN, filed 2 Form D notices with the SEC between 2022 and 2024. The latest, on January 12, 2024, reports $800,000 sold of a $800,000 offering to 9 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 7210 N. PENNSYLVANIA STREET, Indianapolis, IN, 46240
- Phone
- (317) 414-6205
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- United States
- Year incorporated
- 2020
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1905806
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jan 12, 2024 | New notice | $800,000 | $800,000 | 9 | Nov 17, 2023 | sec.gov | |
| Jan 21, 2022 | New notice | $1,000,000 | $950,000 | $50,000 | 11 | Jan 12, 2022 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| John Foglesong | Executive Officer, Director | |
| Brian Blagg | Director |
Other biotechnology companies in Indiana that filed recently
- PAHTIA TECHNOLOGIES INC $25,000 · Sep 17, 2026
Every Form D from the week of Jan 8, 2024 · All recent filings in Indiana · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Grannus Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.